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ABSTRACT: The palladium-catalyzed O-allylation of α-hydroxyphosphonates and α-hydroxyamides obtained from Pudovik and 
Passerini multicomponent reactions has allowed an interesting and highly straightforward access to a variety of building blocks for 
product diversification. These post-functionalizations include a selective base- or ruthenium hydride-mediated isomeriza-
tion/Claisen rearrangement cascade and a ring-closing metathesis that allows access to a variety of diversely functionalized 
phosphono-oxaheterocycles. 
INTRODUCTION 
For several decades now, metal-catalyzed reactions have 
become an increasingly important subset of synthetic tools to 
assemble molecules. Among them, the palladium-catalyzed 
allylic alkylation, also referred to as the Tsuji-Trost reaction, 
has been recognized as an essential tool for the construction of 
C−C bonds. Indeed, this reaction allows to easily incorporate 
an allyl group onto an in situ generated C-centered nucleophile 
under mild conditions.1 Another interesting application is the 
construction of C−O bonds, however this approach has been 
much less explored.2,3 In our quest to implement the 
palladium-catalyzed allylic alkylation to new substrates,4 we 
became interested in applying this chemistry to 
α-hydroxyphosphonates, also known as Pudovik adducts 
(Figure 1). Indeed, we were intrigued by the possibility of the 
alkoxide intermediate to undergo either a direct O-allylation or 
a competing C-allylation resulting from a preliminary 
phospha-Brook rearrangement that is know to occur under 
basic conditions, and which would afford a mixture of C- and 
O-allylated products. Our seminal investigation led to the 
conclusion that the phospha-Brook rearrangement did not 
occur under the palladium conditions and that the O-allylation 
product was formed exclusively, thus offering an interesting 
solution to an unaddressed synthetic challenge, namely the 
alkylation of α-hydroxyphosphonates.5 Since then, we have 
applied this palladium-catalyzed O-allylation to a wider range  
 
Figure 1. O-Allylated Passerini and Pudovik adducts: Useful 
platforms for product diversification. 
of α-hydroxyphosphonate derivatives and eventually extended 
the method to yet another interesting family of compounds, 
namely α-hydroxyamides, also referred to as Passerini 
adducts. In addition, we have showcased the synthetic utility 
of the resulting products by subjecting them to various key 
post-transformations as a mean to access valuable building 
blocks. We report here in full the results of our efforts. 
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RESULTS AND DISCUSSION 
To begin this endeavour, a first α-hydroxyphosphonate (2a) 
was synthesized using standard Pudovik conditions [diethyl 
phosphite (1 equiv.), NEt3 (0.5 equiv.), 50 °C, 24 h] and sub-
jected to slightly optimized palladium-catalyzed allylic alkyla-
tion conditions [Pd2dba3 (2.5 mol %), PPh3 (10 mol %), 
Cs2CO3 (0.25 equiv.), toluene, 50 °C, 30 min] using allyl 
methyl carbonate as an allyl donor (Scheme 1). Interestingly, 
the C-allylated product was not observed, but instead the 
reactions led to the formation of the corresponding O-allylated 
product 5a. Considering the difficulty in making this type of 
compounds under more traditional alkylating conditions which 
favor the phospha-Brook rearrangement, we decided to further 
investigate this reaction.A set of diversely substituted 
α-hydroxyphosphonates were therefore synthesized. As a 
general trend, all the Pudovik adducts (2a-q) were obtained in 
excellent yields after simple evaporation and filtration over a 
pad of silica gel to remove any traces of phosphite, which 
were found to inhibit the subsequent allylation step. The reac-
tion proved to be compatible with different phosphites (2a-c) 
as well as a wide range of aldehydes, including aromatic 
(2a-g) and α,β-unsaturated aldehydes (2p-r), albeit some 
phosphonates were obtained in slightly lower yields such as 
the heteroaromatic (2h-n) and the aliphatic derivatives (2o). 
Going forward, the conditions established for the allylation of 
2a efficiently provided a set of structurally diverse α-allyloxy-
phosphonates. The influence of the phosphite was minimal, 
though the smaller dimethyl phosphite 5b was obtained in a 
slightly higher yield (94%) than the diethyl and diisopropyl 
analogues 5a (90%) and 5c (90%). Both electron-rich and 
electron-poor aryls substituents were well-tolerated (78-97% 
yield, 5a-g). Similarly, heteroaryl-containing substrates also 
led to high yields (71-98% yield, 5h-n), although the 
formation of the 3-pyridyl derivative 5h required a longer 
reaction time (12 h vs 30 min). This lower reactivity was also 
observed with the aliphatic precursor 2o, which required a 
slightly higher temperature (100 °C) to generate the desired 
product 5o (67%). The influence of the allyl moiety was 
also evaluated. Interestingly, while the use of the branched 
methallyl carbonate did not hamper the reaction (5s, 88%), 
we observed slightly lower yields when using the linear 
cinnamyl carbonate instead (60-64% for 5t and 5u vs 85-96% 
for 5g and 5i). Finally, the more hindered quaternary 
α-hydroxyphosphonates 2s and 2t derived from the 
corresponding methyl ketone precursors6 led to the α-allylated 
products 5v and 5w, albeit in 27% and 21% yield respectively. 
To extend the scope of the palladium-catalyzed allylic 
alkylation, we next turned our attention towards a related 
family of compounds, namely α-hydroxyamides. The latter 
were prepared via a Passerini multicomponent reaction by 
reacting various cinnamaldehydes with the corresponding 
isocyanate in the presence of boric acid.7 The resulting 
Passerini adducts were then subjected to the same allylic 
alkylation conditions as previously with the exception that 
Cs2CO3 was not used as it appeared to be unnecessary. To our 
delight, the corresponding O-allylated products 6a-e were all 
obtained in high yields ranging from 77 to 84%. 
With these O-allylated products in hand, we next set out to 
demonstrate their synthetic utility by running several diversifi-
cations. 
The first one that came into our mind involved the 
O-allylated cinnamyl derivatives 5p-r and 6a-d. Indeed, these 
two families of bis-allyl ethers have in common a relatively 
acidic allylic proton, with the styryl group further activating 
the electron-withdrawing character of the amide and the 
phosphonate, as well as an allylic position that can potentially 
be activated by a metal. As such, a base-mediated process 
would trigger an isomerization of the cinnamyl double bond,8 
while a ruthenium-,9,10 rhodium11 or iridium-based12 catalyst 
would selectively promote the isomerization of the other non 
styrenyl double bond. In both cases, the resulting allyl vinyl 
ethers can undergo subsequent Claisen rearrangement to 
generate two very different 1,4-alkenyl carbonyl derivatives 
via a chair-like transition state (Schemes 2 and 4).13 This 
one-pot 1,2-H isomerization/Claisen rearrangement sequences 
have been repeatedly implemented to build structurally 
complex products from simpler, more accessible diallyl 
ethers,14 however, this strategy is not without challenges as 
both double bonds are susceptible to isomerization, resulting 
in possible mixtures. 
With this in mind, we first started by evaluating the base-
mediated isomerization/Claisen rearrangement cascade on the 
O-allylated Passerini adducts 6a-d. The results are depicted in 
Scheme 3. When O-allylamide 6a was heated in the 
presence of triethylamine or Cs2CO3 and toluene at 120 °C 
under microwave irradiation, unreacted starting material was 
recovered. Interestingly, switching to DBU (0.5 equiv.) under 
otherwise identical conditions led to the desired α-ketoamide 
7a in 65% yield.8 These conditions were eventually applied to 
the allyloxy amides 6b-d affording the desired α-ketoamides 
7b-d in 76-88% yield (Scheme 2). 
This DBU-mediated isomerization was eventually applied 
to the Pudovik adducts 5p-r. To our surprise, when the 
corresponding phosphonate ethers were exposed to our 
optimized conditions, intractable mixtures of products were 
obtained. Replacing toluene with acetonitrile or DMF did not 
improve the result. In an effort to analyze the potential 
issues associated with the formation of α-ketophosphonates 
under these conditions, we reasoned that the latter could 
potentially be decomposing under basic conditions or even 
undergo ketene formation. Indeed, ketophosphonates are 
known for their behavior as acylating agents with the 
phosphonyl group being easily displaced by various nucleo-
philes. To validate our hypothesis, we ran the reactions in the 
presence of various primary amines. To our delight, the corre-
sponding amides 9a-d were formed, albeit in moderate yields 
ranging from 56 to 77%. Piperidine was found to be less 
reactive affording amide 9e in only 38% isolated yield. 
NH indoles could also be used as showcased by the formation 
of the acylated indoles 9f-g. Unfortunately, attempts to direct 
the reaction towards C-acylated indoles using N-methyindole 
led to unidentified mixtures. The reaction can also be run in a 
nucleophilic solvent such as ethanol or trifluoroethanol to 
afford the corresponding esters 9i and 9j in 89% and 53% 
yields respectively. The reaction was eventually extended to 
the formation of thioesters by running the reaction in a 2:1 
toluene/thiol solution and heating at 150 °C under microwave 
irradiation; the corresponded thioester 9k was formed in 67% 
yield (Scheme 3). 
Having prepared a number of α,α-diallyloxyphosphonates, 
we then evaluated the possibility of reorganizing their 
structure using a metal-catalyzed approach.15 Treating 5q with 
RuClH(CO)(PPh3)3 in toluene under microwave irradiation 
(120 °C, 30 min) led to the formation of the Claisen 
rearrangement product 10a in 41% yield and a 2:1 
diastereomeric ratio (Scheme 4). We then applied our initial 
 
reaction conditions [RuClH(CO)(PPh3)3 (5 mol %), 120 °C 
(MW), toluene, 30 min] to the O-allyl Passerini adducts 6a-c. 
The latter were readily converted to the corresponding 
α,β-unsaturated amides 10b-d in moderate to good yields 
ranging from 69 to 85% albeit in a roughly 1:1 mixture of 
diastereoisomers. 
When the ruthenium-catalyzed isomerization conditions 
were applied to compound 5i, we observed the formation of 
the disubstituted heterocycle 11a. After slightly optimizing the 
reaction conditions (reaction run in chloroform at 180 °C for 
10 min under microwave irradiation), we were able to increase 
the yield to 62% (Scheme 5). These conditions were 
eventually applied to a series of heterocyclic O-allylated 
derivatives (5j-n and 6e), resulting in the formation of the 
corresponding disubstituted heterocycles 11b-g in yields 
ranging from 29 to 62%. The conditions were also applied to 
the quinoline derivative 5x (structure not shown), affording 
the disubstituted quinoline 11h in 45% yield. 
Finally, we turned our attention to the synthesis of 
phosphono-oxaheterocycles by subjecting various Pudovik 
adducts bearing a pendent olefin to ring-closing metathesis 
(RCM) conditions (Scheme 6).16 To this end, we prepared 
 
Scheme 1. Sequential DBU-mediated isomerization/Claisen rearrangement. 
  
a All the reactions were run on a 1 mmol scale (yields reported are isolated yields). b Reaction run under mechanical stirring. c Reaction ran at 50 °C for 2 h (5f) and 12 h 
(5h). d Reaction ran at 100 °C. e Reaction ran for 1.5 h. f Reaction ran for 2 h. g Prepared from acetophenone. h 50% starting ketone recovered. i Reaction ran for 1 h in the 
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Scheme 2. Sequential DBU-mediated isomerization/Claisen rearrangement. 
 
Scheme 3. Sequential DBU-mediated isomerization/Claisen rearrangement. 
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All the reactions were run on a 0.5 mmol scale. a Yields reported are isolated yields). b Reaction run in DMF at 140 °C
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Sequential RuClH(CO)(PPh3)3-catalyzed isomerization/Claisen rearrangement




5q [X = PO(OEt)2]





MeRuClH(CO)(PPh3)3 (5 mol %)
















41% (dr = 1:1)







Scheme 5. Pudovik and Passerini adduct modification: Sequential Ru-catalyzed isomerization/Claisen rearrangement. 
Scheme 6. Pudovik adduct modification: Sequential O-allylation/RCM. 
 




All the reactions were run on a 0.1 mmol scale. a Yields reported are isolated yields.
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All the reactions were run on a 1 mmol scale (yields reported are isolated yields). aRequired 6 mol % catalyst loading. bDetermined by NMR analysis on the crude reaction 
mixture.
Pudovik and Passerini adduct modification
92%89% 82% 81%
14d14a 14b 14c






























a range of dienes of various length 13a-g and subjected them 
to standard RCM conditions using Grubbs’ second-generation 
catalyst, GII (4 mol %) in refluxing CH2Cl2 (100 mM 
concentration). Under these conditions, the smaller rings, such 
as the dihydrofuran 14a (89%), the dihydropyrane 14b (82%) 
and the oxepin 14c (81%) were obtained in high yields. 
Benzooxepin 14d was obtained with an even higher yield of 
92%. The larger derivatives such as the 14-, 15- and 
16-phosphono-oxaheterocycles could also be effectively 
accessed, however they required more dilute conditions 
(1 mM) to avoid any undesired oligomerization. Of note is the 
efficient formation of [12] and [13]metacyclophanes 14f and 
14g which were obtained in 69 and 99% yield, respectively. 
All three macrocycles were obtained as a mixture of E/Z 
isomers in a consistent ratio of 4:1 as assessed by 13C NMR. 
This selectivity is in agreement with previous results observed 
with the widely available Grubbs' second-generation cata-
lyst.17  
CONCLUSION 
In summary, we have developed orthogonal catalytic 
conditions for a cascade isomerization/Claisen rearrangement 
starting from O-allyl Pudovik and Passerini adducts. The 
presence of the amido or phosphono substituents is highly 
beneficial as it increases the acidity of the starting materials 
thus allowing a more efficient isomerization/Claisen cascade 
under basic conditions. The applicability of the method is 
further demonstrated by trapping the acylphosphonate 
intermediates of Pudovik adducts with various oxygen or 
nitrogen nucleophiles, allowing to access diverse compounds. 
A switch in the selectivity of the isomerization was achieved 
when a ruthenium hydride catalyst was used. 
EXPERIMENTAL SECTION 
General methods. All reactions were carried out in sealed 
tubes. Column chromatography was carried out on silica gel. 
1H NMR spectra were obtained with tetramethylsilane 
(δ = 0 ppm) as an internal standard in CDCl3 using a Bruker 
AVANCE 400 spectrometer (400 MHz). Data are reported as 
follows: chemical shift in ppm, apparent multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, 
m = multiplet or overlap of non-equivalent resonances), 
coupling constants, integration. 13C NMR spectra were record-
ed at 100 MHz and residual solvent peaks were used as an 
internal reference (CHCl3 δ 77.16). Data are reported as 
follows: chemical shift in ppm, multiplicity deduced from 
DEPT experiments (CH3, CH2, CH, Cq), apparent multiplicity, 
coupling constants and integration where relevant. IR spectra 
were recorded on a Perkin Elmer Spectrum 65 FT-IR Spec-
trometer. Melting points were measured on a Stuart SMP3 
melting point apparatus and are uncorrected. Low-resolution 
mass spectra were recorded on an Agilent 1100 series LC-MS 
(with a 6310 ion trap) under electrospray ionization (ESI). For 
compounds containing bromine, the mass of 79Br was used. 
All commercially available compounds were used without 
further purification. Compounds 2a-l, 2o-r, 2t, 5a-i, 5o, 5q, 
5t-u, 5w, 12a-g, 13a-g and 14a-g have already been reported 
and therefore won’t be described here; the spectral data 
matched those reported in the literature. Compounds 2r and 
2u were prepared and engaged in the allylation step without 
further purification. 
General procedure for the synthesis of the α-hydroxy-
phosphonates. A mixture of aldehyde (1.01 equiv.), diethyl 
phosphite (1.00 equiv.) and triethylamine (0.50 equiv.) was 
stirred at room temperature or 50 °C for the indicated time. 
The reaction mixture was then diluted with chloroform and 
concentrated under reduced pressure to remove NEt3. 
Dimethyl [hydroxy(4-nitrophenyl)methyl]phosphonate 
(2d). Compound 2d was prepared by mechanically stirring 
4-nitrobenzaldehyde (831 mg, 5.5 mmol, 1.1 equiv.), 
dimethylphosphite (0.46 mL, 5.0 mmol, 1.0 equiv.) and 
triethylamine (0.35 mL, 2.5 mmol, 0.5 equiv.). The title 
compound was obtained as an orange solid (1.2 g, 4.6 mmol, 
91%) after a very fast reaction completed in five minutes and 
immediately purified by flash column chromatography over 
silica gel (CH2Cl2/EtOAc, 100:0 to 0:100). Spectral data 
matched those reported in the literature.5 1H NMR (400 MHz, 
CDCl3) δ 8.23 (d, J = 8.7 Hz, 2H), 7.67 (dd, J = 8.7, 2.2 Hz, 
2H), 5.22 (d, J = 12.3 Hz, 1H), 4.79 (brs, 1H), 3.78 (d, 
J = 8.9 Hz, 3H), 3.75 (d, J = 9.0 Hz, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 147.8 (d, J = 3.7 Hz), 143.9, 127.7 (d, 
J = 5.3 Hz, 2C), 123.6 (d, J = 2.6 Hz, 2C), 70.1 (d, J = 158.6 
Hz), 54.6 (d, J = 7.1 Hz), 53.9 (d, J = 7.6 Hz). IR (thin film): 
3246, 2958, 2854, 1518, 1347, 1236, 1027, 864 cm-1. HRMS 
(ESI) m/z: [M]+ calcd for C9H12NO6P 261.0402; Found 
261.0396. 
Diethyl [(allyloxy)(benzo[b]thiophen-2-yl)methyl]phos-
phonate (2m). Colourless oil, 208 mg, 69X% isolated yield. 
Rf = 0.45 (PE/Et2O = 1:5). 1H NMR (400 MHz, CDCl3) δ 7.82 
(dd, J = 4.6, 3.9 Hz, 1H), 7.75 (dd, J = 8.4, 6.4 Hz, 1H), 7.42 
(d, J = 3.4 Hz, 1H), 7.37-7.29 (m, 2H), 5.31 (ddd, J = 11.7, 
5.5, 1.0 Hz, 1H), 4.22-4.10 (m, 4H), 3.29 (dd, J = 9.2, 5.5 Hz, 
1H), 1.36-1.25 (m, 6H). 13C{1H} NMR (101 MHz, CDCl3) 
δ 140.1 (dd, J = 15.4, 2.1 Hz), 124.6 (d, J = 9.2 Hz), 123.9, 
122.8 (d, J = 8.2 Hz), 122.5, 67.9 (d, J = 164.3 Hz), 63.8 (d, 
J = 7.0 Hz), 63.8 (d, J = 10.6 Hz), 16.6. IR (thin film): 3250, 
2985, 1439, 1205 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C13H17O4PSNa 323.0483; Found 323.0506. 
Diethyl [(allyloxy)(benzo[b]thiophen-3-yl)methyl]phos-
phonate (2n). Colorless oil, 218 mg, 73% isolated yield. 
Rf = 0.45 (PE/Et2O = 1:5). 1H NMR (400 MHz, CDCl3) 
δ 7.93-7.89 (m, 1H), 7.88-7.84 (m, 1H), 7.74 (dd, J = 3.4, 
0.5 Hz, 1H), 7.42-7.33 (m, 2H), 5.42 (ddd, J = 11.0, 5.8, 
0.8 Hz, 1H), 4.17-3.86 (m, 4H), 3.70 (dd, J = 8.6, 5.8 Hz, 1H), 
1.27 (tt, J = 2.3, 1.2 Hz, 3H), 1.14 (tt, J = 5.3, 2.7 Hz, 3H). 
13C{1H} NMR (101 MHz, CDCl3) δ 140.5, 137.5 (d, 
J = 5.9 Hz), 131.8, 125.6 (d, J = 7.4 Hz), 124.7, 124.3, 122.8 
(d, J = 16.2 Hz), 66.4 (d, J = 164.2 Hz), 63.5 (d, J = 7.1 Hz), 
63.4 (d, J = 7.2 Hz), 16.5 (dd, J = 12.3, 5.6 Hz). IR (thin film): 
3200, 2980, 1430, 1203 cm-1. HRMS (ESI) m/z: [M + Na]+ 
calcd for C13H17O4PSNa 323.0483; Found 323.0506. 
Diethyl (1-hydroxy-1-phenyl)ethylphosphonate (2s). 
n-BuLi (as a 2.5 M solution in hexanes, 2.1 µL, 5.3 µmol) and 
diethyl phosphite (822 µL, 6.38 mmol, 1.2 equiv.) were mixed 
under dry nitrogen. The mixture was stirred for 5 min before 
acetophenone (0.62 mL, 5.0 mmol, 1.0 equiv.) was added at 
0 °C. The resulting mixture was allowed to stir at the same 
temperature for 5 min and the reaction was quenched by 
addition of EtOAc (3 mL) and H2O (2 mL). The layers were 
separated and the aqueous phase was extracted with EtOAc 
(2 x 5 mL). The combined organic phases were dried over 
anhydrous MgSO4 and concentrated under reduced pressure. 
The crude residue was co-evaporated with toluene several 
times to remove traces of phosphite and purified by flash 
column chromatography over silica gel with a gradient of 
EtOAc in petroleum ether (50/50 to 70/30). The title 
compound 2s was obtained as white crystals (1,3 g, 5.2 mmol, 
98%). Rf = 0.31 (CH2Cl2/EtOAc = 7:3). mp = 77-78 °C. 
1H NMR (400 MHz, CDCl3) δ 7.63-7.58 (m, 2H), 7.35 (t, 
 
 
J = 7.3 Hz, 2H), 7.28 (dd, J = 7.3, 1.7 Hz, 1H), 4.15-3.80 (m, 
4H), 3.66 (brs, 1H, OH), 1.82 (d, J = 15.5 Hz, 3H), 1.25 (t, 
J = 7.1 Hz, 3H), 1.19 (t, J = 7.1 Hz, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 141.1, 128.1 (d, J = 2.5 Hz), 127.5 (d, 
J = 2.9 Hz), 126.0 (d, J = 4.3 Hz), 73.6 (d, J = 158.6 Hz), 63.4 
(d, J = 4.3 Hz), 63.4 (d, J = 4.4 Hz), 26.1 (d, J = 3.9 Hz), 16.5 
(d, J = 5.7 Hz), 16.4 (d, J = 6.0 Hz). IR (thin film): 3580, 
3382, 2997, 2932, 1496, 1247, 970 cm-1. HRMS (ESI) m/z: 
[M]+ calcd for C12H19O4P 258.1021; Found 258.1016. 
General procedure for the synthesis of α-hydroxyamides 
(3a-e). A mixture of aldehyde (5 mmol), isocyanide (5 mmol) 
and boric acid (5 mmol) in DMF (1 mL) was stirred at 50 °C 
using a heating mantle for 24 h. The crude solution was then 
diluted with 100 mL of Et2O and washed two times with 10 
mL of water. After evaporation of the solvent under reduced 
pressure, the crude residue was purified by flash chromatog-
raphy over silica gel. 
 (E)-N-(tert-Butyl)-2-hydroxy-4-(4-methoxyphenyl)but-3-
enamide (3a). Yellow solid, 1.13 g, 86% isolated yield. 
Rf = 0.38 (PE/Et2O = 3:7). mp = 135-137 °C. 1H NMR 
(400 MHz, CDCl3) δ 7.32 (d, J = 8.6 Hz, 2H), 6.84 (d, 
J = 8.6 Hz, 2H), 6.65 (d, J = 15.8 Hz, 1H), 6.10 (dd, J = 15.8, 
7.1 Hz, 1H), 6.07 (brs, 1H), 4.54 (ddd, J = 7.1, 3.7, 1.0 Hz, 
1H), 3.80 (s, 3H), 3.67 (brs, 1H), 1.36 (s, 9H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 171.4, 159.7, 133.1, 128.9, 128.1, 125.0, 
114.1, 73.2, 55.4, 51.6, 28.8. IR (thin film): 3364, 2964, 2932, 
2836, 1644, 1605, 1510, 1454, 1364, 1245, 1173, 1029, 978, 
828, 788 cm-1. HRMS (ESI) m/z: [M]+ calcd for C15H21NO3 
263.1521; Found 263.1521. 
(E)-N-Cyclohexyl-2-hydroxy-4-(4-methoxyphenyl)but-3-
enamide (3b). Yellow solid, 1.18 g, 82% isolated yield. 
Rf = 0.23 (PE/Et2O = 3:7). mp = 95-97 °C. 1H NMR 
(400 MHz, CDCl3) δ 7.33 (d, J = 8.8 Hz, 2H), 6.86 (d, 
J = 8.8 Hz, 2H), 6.70 (d, J = 15.9 Hz, 1H), 6.50 (brs, 1H), 6.18 
(dd, J = 15.9, 6.5 Hz, 1H), 4.69 (d, J = 6.5 Hz, 1H), 4.30 (br, 
1H), 3.83 (s, 3H), 3.81-3.70 (m, 1H), 1.98-1.86 (m, 2H), 1.78-
1.57 (m, 3H), 1.45-1.29 (m, 2H), 1.26-1.08 (m, 3H). 
13C{1H} NMR (101 MHz, CDCl3) δ 171.5, 159.5, 132.3, 
128.9, 128.0, 124.9, 114.0, 72.9, 55.3, 48.4, 33.0, 25.5, 24.8. 
IR (thin film): 3393, 3052, 2934, 2856, 1645, 1607, 1511, 
1264, 1249, 1174, 1033, 825, 732 cm-1. HRMS (ESI) m/z: 
[M]+ calcd for C17H23NO3 289.1678; Found 289.1685. 
 (E)-N-(tert-Butyl)-2-hydroxy-4-phenylbut-3-enamide 
(3c). Yellow solid, 961 mg, 82% isolated yield. Rf = 0.30 
(PE/Et2O = 4:6). mp = 95-97 °C. 1H NMR (400 MHz, CDCl3) 
δ 7.35-7.29 (m, 2H), 7.28-7.16 (m, 3H), 6.65 (dd, J = 15.9, 
0.8 Hz, 1H), 6.19 (dd, J = 15.9, 6.9 Hz, 1H), 6.01 (brs, 1H), 
4.51 (dd, J = 6.9, 2.6 Hz, 1H), 3.61 (brs, 1H), 1.29 (s, 9H). 
13C{1H} NMR (101 MHz, CDCl3) δ 171.1, 136.1, 133.4, 
128.7, 128.3, 127.3, 126.9, 73.1, 51.6, 28.9. IR (thin film): 
3384, 3055, 2970, 1658, 1649, 1525, 1454, 1366, 1264, 1223, 
966, 909, 732 cm-1. HRMS (ESI) m/z: [M]+ calcd for 
C14H19NO2 233.1416; Found 233.1409. 
(E)-N-Cyclohexyl-4-(furan-2yl)-2-hydroxybut-3-enamide 
(3d). Red oil 887 mg, 71% isolated yield. Rf = 0.33 
(PE/Et2O = 2:8). 1H NMR (400 MHz, CDCl3) δ 7.32 (d, 
J = 1.8 Hz, 1H), 6.55 (dd, J = 15.8, 1.4 Hz, 1H), 6.44 (br, 1H), 
6.34 (dd, J = 3.3, 1.8 Hz, 1H), 6.29-6.13 (m, 2H), 4.64 (brs, 
1H), 4.13 (br, 1H), 3.87-3.46 (m, 1H), 1.95-1.81 (m, 2H), 
1.75-1.05 (m, 3H), 1.40-1.24 (m, 2H), 1.22-1.02 (m, 3H). 
13C{1H} NMR (101 MHz, CDCl3) δ 171.1, 152.0, 142.4, 
125.7, 120.7, 111.5, 109.0, 72.4, 48.5, 33.0, 25.5, 24.9. 
IR (thin film): 3302, 2964, 2932, 2855, 1642, 1526, 1450, 
1264, 1013, 959, 731, 702 cm-1. HRMS (ESI) m/z: [M]+ calcd 
for C14H19NO3 249.1365; Found 249.1622. 
N-Cyclohexyl-4-(furan-2yl)-2-hydroxyacetamide (3e). 
Brown solid, 910 mg, 81% isolated yield. Rf = 0.3 
(PE/Et2O = 2:8). mp = 85-87 °C. 1H NMR (400 MHz, CDCl3) 
δ 7.36 (dd, J = 1.8, 0.8 Hz, 1H), 6.42 (br, 1H), 6.33-6.31 (m, 
2H), 5.02 (d, J = 2.7 Hz, 1H), 4.30 (brs, 1H), 3.99-3.34 (m, 
1H), 1.95-1.79 (m, 2H), 1.74-1.51 (m, 3H), 1.40-1.26 (m, 2H), 
1.23-1.05 (m, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 169.1, 
152.2, 142.9, 110.6, 108.4, 67.7, 48.6, 32.9, 32.8, 25.5, 24.9, 
24.8. IR (thin film): 3288, 2929, 1853, 1647, 1529, 1450, 
1252, 1223, 1150, 1059, 1012, 809, 739 cm-1. HRMS (ESI) 
m/z: [M]+ calcd for C12H17NO3 223.1208; Found 223.1208. 
General procedure for the Pd-catalyzed O-allylation of 
α-hydroxyphosphonates. To a solution of α-
hydroxyphosphonate (1.0 mmol) in toluene (0.5 M solution) 
was added Pd2(dba)3 (0.025 mmol), allyl methyl carbonate 
(1.0 mmol), triphenylphosphine (0.1 mmol) and Cs2CO3 
(0.25 mmol). The resulting mixture was stirred at the 
indicated temperature using a heating mantle for the indicated 
amount of time. The reaction mixture was then filtered over a 
pad of Celite and concentrated under reduced pressure. 
Diethyl[(allyloxy)(thiophen-2-yl)methyl]phosphonate 
(5j). Yellow oil, 210 mg, 72% isolated yield. Rf = 0.55 
(PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) δ 7.33 (dt, 
J = 5.1, 1.4 Hz, 1H), 7.18-7.10 (m, 1H), 7.01 (ddd, J = 5.0, 
3.5, 0.6 Hz, 1H), 5.87 (dddd, J = 17.1, 10.4, 6.6, 5.1 Hz, 1H), 
5.25 (dddd, J = 10.4, 3.9, 3.0, 1.4 Hz, 2H), 4.95 (d, 
J = 15.7 Hz, 1H), 4.22-3.93 (m, 6H), 1.32-1.22 (m, 6H). 
13C{1H} NMR (101 MHz, CDCl3) δ 137.6 (d, J = 2.0 Hz), 
133.7, 127.8 (d, J = 8.1 Hz), 126.9 (d, J = 2.5 Hz), 126.7 (d, 
J = 3.4 Hz), 118.7, 72.9 (d, J = 176.9 Hz), 71.2 (d, 
J = 12.9 Hz), 63.5 (d, J = 7.0 Hz), 63.4 (d, J = 6.8 Hz), 16.6 
(d, J = 5.7 Hz), 16.5 (d, J = 5.8 Hz). IR (thin film): 2989, 
1717, 1262, 1028 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C12H19O4PSNa 313.0639; Found 313.0685. 
Diethyl[(allyloxy)(furan-3-yl)methyl]phosphonate (5k). 
Yellow oil, 242 mg, 89% isolated yield. Rf = 0.36 
(PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) δ 7.51-7.47 
(m, 1H), 7.41 (t, J = 1.7 Hz, 1H), 6.56-6.51 (m, 1H), 5.86 
(dddd, J = 16.8, 10.4, 6.4, 5.2 Hz, 1H), 5.24 (ddq, J = 18.8, 
10.4, 1.4 Hz, 2H), 4.67 (d, J = 14.8 Hz, 1H), 4.19-4.03 (m, 
5H), 4.00-3.93 (m, 1H), 1.36-1.18 (m, 6H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 143.5, 141.8 (d, J = 11.2 Hz), 134.0, 
119.7 (d, J = 1.4 Hz), 118.4, 110.4 (d, J = 3.6 Hz), 71.0 (d, 
J = 12.3 Hz), 69.6 (d, J = 175.5 Hz), 63.3 (d, J = 6.9 Hz), 63.1 
(d, J = 6.7 Hz), 17.8-15.1 (m). IR (thin film): 2980, 1727, 
1242, 1048 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C12H19O5PNa 297.0867; Found 297.0855. 
Diethyl[(allyloxy)(thiophen-3-yl)methyl]phosphonate 
(5l). Yellow oil, 210 mg, 71% isolated yield. Rf = 0.55 
(PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) δ 7.33 (dddd, 
J = 12.0, 8.0, 3.1, 1.8 Hz, 2H), 7.19 (dt, J = 4.9, 1.1 Hz, 1H), 
5.87 (dddd, J = 16.9, 10.4, 6.4, 5.1 Hz, 1H), 5.23 (ddq, 
J = 17.7, 10.4, 1.4 Hz, 2H), 4.82 (d, J = 15.1 Hz, 1H), 4.18-
3.91 (m, 6H), 1.29-1.20 (m, 6H). 13C{1H} NMR (101 MHz, 
CDCl3) δ 135.9 (d, J = 1.4 Hz), 134.0, 127.5 (d, J = 3.7 Hz), 
126.1 (d, J = 1.3 Hz), 124.3 (d, J = 9.4 Hz), 118.3, 73.4 (d, 
J = 172.5 Hz), 71.3 (d, J = 12.9 Hz), 63.3 (d, J = 6.9 Hz), 63.1 
(d, J = 6.8 Hz), 16.6 (d, J = 5.7 Hz), 16.5 (d, J = 5.8 Hz). 
IR (thin film): 2985, 1372, 1257, 1048 cm-1. HRMS (ESI) m/z: 
[M + Na]+ calcd for C12H19O4PSNa 313.0639; Found 
313.0685. 
Diethyl[(allyloxy)(benzo[b]thiophen-2-yl)methyl]-
phosphonate (5m). Yellow oil, 334 mg, 98% isolated yield. 
Rf = 0.47 (PE/EtOAc = 1:5). 1H NMR (400 MHz, CDCl3) 
δ 7.85-7.80 (m, 1H), 7.77-7.72 (m, 1H), 7.39-7.30 (m, 3H), 
 
 
5.91 (dddd, J = 17.1, 10.4, 6.6, 5.1 Hz, 1H), 5.34-5.22 (m, 
2H), 5.04 (dd, J = 16.2, 0.7 Hz, 1H), 4.29-4.00 (m, 6H), 1.33-
1.25 (m, 6H). 13C{1H} NMR (101 MHz, CDCl3) δ 140.4, 
139.5 (d, J = 2.4 Hz), 139.0 (d, J = 2.6 Hz), 133.6, 124.5 (d, 
J = 18.5 Hz), 124.3 (d, J = 8.9 Hz), 123.8, 122.5, 119.0, 73.6 
(d, J = 175.1 Hz), 71.6 (d, J = 12.9 Hz), 63.7 (d, J = 7.0 Hz), 
63.5 (d, J = 6.8 Hz), 16.7-16.4 (m). IR (thin film): 2985, 1728, 
1261, 1048 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C16H21O4PSNa 363.0795; Found 363.0802. 
Diethyl[(allyloxy)(benzo[b]thiophen-3-yl)methyl] 
phosphonate (5n). Yellow oil, 334 mg, 98% isolated yield. 
Rf = 0.45 (PE/EtOAc = 1:5). 1H NMR (400 MHz, CDCl3) 
δ 8.01-7.97 (m, 1H), 7.88-7.83 (m, 1H), 7.61 (d, J = 3.6 Hz, 
1H), 7.37 (pd, J = 7.1, 1.4 Hz, 2H), 5.88 (dddd, J = 17.0, 10.4, 
6.4, 5.1 Hz, 1H), 5.31-5.12 (m, 3H), 4.21-3.85 (m, 6H), 1.28-
1.21 (m, 3H), 1.18-1.10 (m, 3H). 13C{1H} NMR (101 MHz, 
CDCl3) δ 140.6, 137.9 (d, J = 4.3 Hz), 133.9, 130.1, 126.6 (d, 
J = 8.5 Hz), 124.7, 124.3, 123.2, 122.8, 118.5, 72.7 (d, 
J = 174.6 Hz), 71.3 (d, J = 13.5 Hz), 63.3 (d, J = 6.8 Hz), 63.1 
(d, J = 6.8 Hz), 16.6 (d, J = 13.9, 5.8 Hz), 16.5 (d, J = 5.8 Hz). 
IR (thin film): 2985, 2868, 1430, 1257 cm-1. HRMS (ESI) m/z: 
[M + Na]+ Calcd for C16H21O4PSNa 363.0795; Found 
363.0802. 
(E)-Diethyl (1-(allyloxy)-3-phenylallyl)phosphonate (5p). 
Yellow oil, 225 mg, 73% isolated yield. Rf = 0.35 
(CH2Cl2/EtOAc = 9:1). 1H NMR (400 MHz, CDCl3) δ 7.41 (d, 
J = 7.4 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 7.29-7.22 (m, 1H), 
6.71 (dd, J = 16.0, 4.1 Hz, 1H), 6.23(ddd, J = 16.0, 7.3, 5.1 
Hz, 1H) 5.95-5.85 (m, 1H), 5.27 (dddd, J = 10.4, 3.9, 2.9, 
1.4 Hz, 2H), 4.36 (ddd, J = 16.2, 7.4,1.2 Hz, 1H), 4.26-4.14 
(m, 5H), 4.07 (ddt, J = 12.9, 6.3, 1.1 Hz, 1H), 1.32 (t, 
J = 7.1 Hz, 6H). 13C{1H} NMR (101 MHz, CDCl3) δ 136.2 (d, 
J = 2.7 Hz), 134.6 (d, J = 13.3 Hz), 134.0, 128.7, 128.2, 
126.8(d, J = 1.6 Hz), 122.6 (d, J = 4.3 Hz), 118.3, 76.0 (d, 
J = 169.2 Hz), 71.25 (d, J = 12.0 Hz), 63.3 (d, J = 7.0 Hz), 63.0 
(d, J = 6.9 Hz), 16.7 (d, J = 3.9 Hz), 16.6 (d, J = 3.9 Hz). 
IR (thin film): 3027, 2980, 2907, 1645, 1241, 1097, 1017, 
963 cm-1. HRMS (ESI) m/z: [M]+ calcd for C16H23O4P 
310.1334; Found 310.1345. 
(E)-Diethyl[1-(allyloxy)-3-(2-methoxyphenyl)allyl] 
phosphonate (5r). Yellow oil, 246 mg, 72% isolated yield. 
Rf = 0.4 (CH2Cl2/EtOAc = 8:2). 1H NMR (400 MHz, CDCl3) 
δ 7.45 (d, J = 7.6 Hz, 1H), 7.24 (m, 1H), 7.02 (dd, J = 16.1, 
4.4 Hz, 1H), 6.92 (t, J = 7.6 Hz), 6.86 (d, J = 8.3 Hz, 1H), 6.23 
(m, 1H), 5.91 (m, 1H), 5.33-5.20 (m, 2H), 4.36 (dd, J = 15.6, 
7.8 Hz, 2H), 4.25-4.03 (m, 6H), 3.83 (s, 3H), 1.32 (t, 
J = 7.0 Hz, 3H), 1.31 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (101 
MHz, CDCl3) δ 157.0 (d, J = 1.2 Hz), 134.1, 130.1 (d, 
J = 13.8 Hz), 129.3, 127.3 (d, J = 1.1 Hz), 125.2 (d, 
J = 2.2 Hz), 123.0 (d, J = 4.2 Hz), 120.7, 118.2, 111.0, 76.6 (d, 
J = 170.1 Hz), 71.0 (d, J = 12.7 Hz), 63.2 (d, J = 6.9 Hz), 63.0 
(d, J = 6.9 Hz), 55.5, 16.6 (d, J = 4.9 Hz), 16.5 (d, J = 5.0 Hz). 
IR (thin film): 3469, 2979, 2838, 1644, 1292, 1077, 963 cm-1. 
HRMS (ESI) m/z: [M]+ calcd for C17H25O5P 340.1440; Found 
340.1445. 
Diethyl (E)-{3-(4-methoxyphenyl)-1-[(2-methylallyl)oxy] 
allyl}phosphonate (5s). Yellow oil (208 mg, 88% isolated 
yield. Rf = 0.4 (CH2Cl2/EtOAc = 4:1). 1H NMR (400 MHz, 
CDCl3) δ 7.39-7.31 (m, 2H), 6.90-6.83 (m, 2H), 6.64 (ddd, 
J = 15.9, 4.5, 1.2 Hz, 1H), 6.07 (ddd, J = 15.9, 7.7, 5.3 Hz, 
1H), 4.99 (s, 1H), 4.94 (s, 1H), 4.30 (ddd, J = 15.5, 7.7, 
1.2 Hz, 1H), 4.24-4.12 (m, 4H), 4.11 (d, J = 12.7 Hz, 1H), 
3.97 (d, J = 12.7 Hz, 1H), 3.81 (s, 3H), 1.76 (s, 3H), 1.31 (td, 
J = 7.1, 3.5 Hz, 6H). 13C{1H} NMR (101 MHz, CDCl3) 
δ 159.8, 141.5, 134.5 (d, J = 13.5 Hz), 129.1 (d, J = 2.6 Hz), 
128.1 (d, J = 1.8 Hz, 2C), 120.2 (d, J = 4.4 Hz), 114.2 (2C), 
113.6, 75.9 (d, J = 170.8 Hz), 73.8 (d, J = 12.1 Hz), 63.2 (d, 
J = 7.0 Hz), 62.9 (d, J = 6.9 Hz), 55.5, 19.7, 16.7 (t, 
J = 5.5 Hz, 2C). IR (thin film): 3469, 2979, 2838, 1644, 1292, 
1077, 963 cm-1. HRMS (ESI) m/z: [M]+ calcd for C18H27O5P 
354.1596; Found 354.1601. 
Diethyl [1-(allyloxy)-1-phenylethyl]phosphonate (5v). 
Colorless oil, 15 mg, 27% isolated yield. Rf = 0.63 
(CH2Cl2/EtOAc = 7:3). 1H NMR (400 MHz, CDCl3) δ 7.55-
7.48 (m, 2H), 7.36 (t, J = 7.4 Hz, 2H), 7.30 (dd, J = 7.4, 
1.7 Hz, 1H), 5.94 (ddt, J = 17.0, 10.4, 5.2 Hz, 1H), 5.31 (dq, 
J = 17.0, 1.7 Hz, 1H), 5.14 (ddd, J = 10.4, 3.0, 1.4 Hz, 1H), 
4.16-3.92 (m, 5H), 3.80 (dd, J = 12.5, 4.8 Hz, 1H), 1.88 (d, 
J = 15.9 Hz, 3H), 1.23 (t, J = 6.1 Hz, 3H), 1.20 (t, J = 6.1 Hz, 
3H). 13C{1H} NMR (101 MHz, CDCl3) δ 138.7, 135.0, 128.2 
(d, J = 2.4 Hz), 127.9 (d, J = 3.2 Hz), 127.8 (d, J = 4.5 Hz), 
116.2, 79.5 (d, J = 169.9 Hz), 64.1 (d, J = 12.7 Hz), 63.4 (d, 
J = 7.1 Hz), 63.3 (d, J = 6.9 Hz), 19.8, 16.5 (d, J = 5.1 Hz), 
16.5 (d, J = 5.2 Hz). IR (thin film): 3403, 3065, 2993, 1446, 
1249, 1057, 1029, 839 cm-1. HRMS (ESI) m/z: [M]+ calcd for 
C15H23O4P 298.1334; Found 298.1336. 
Diethyl [(allyloxy)(quinolin-3-yl)methyl]phosphonate 
(5x). Yellow oil, 212 mg, 63% isolated yield. Rf = 0.2 
(EtOAc = 100%). 1H NMR (400 MHz, CDCl3) δ 8.90 (s, 1H), 
8.24 (t, J = 2.4 Hz, 1H), 8.07 (d, J = 8.5 Hz, 1H), 7.81 (d, 
J = 8.1 Hz, 1H), 7.69 (t, J = 7.5 Hz, 1H), 7.52 (t, J = 7.0 Hz, 
1H), 5.98-5.72 (m, 1H), 5.27-5.19 (m, 2H), 4.89 (d, 
J = 16.1 Hz, 1H), 4.31-3.70 (m, 6H), 1.23 (t, J = 7.1 Hz, 3H), 
1.21 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3) 
δ 150.2 (d, J = 5.0 Hz), 148.1 (d, J = 2.1 Hz), 135.4 (d, 
J = 6.5 Hz), 133.4, 129.9, 129.3, 128.2 (d, J = 1.6 Hz), 128.1, 
127.7 (d, J = 2.5 Hz), 127.0, 118.9, 75.16 (d, J = 170.5 Hz), 
71.7 (d, J = 13.0 Hz), 63.4 (d, J = 7.1 Hz), 63.2 (d, 
J = 7.0 Hz), 16.5 (d, J = 5.3 Hz), 16.4 (d, J = 5.3 Hz).	IR (thin 
film): 3052, 2982, 2932, 1496, 1253, 1046, 1020, 963, 788, 
731, 700 cm-1. HRMS (ESI) m/z: [M]+ calcd for C17H22NO4P 
335.1286; Found 335.1281. 
General procedure for the Pd-catalyzed O-allylation of 
α-hydroxyamides. To a solution of α-hydroxyamide 
(2.0 mmol) in toluene (0.5 M solution) were added Pd2(dba)3 
(0.05 mmol), allyl methyl carbonate (2.0 mmol) and 
triphenylphosphine (0.2 mmol) and the resulting mixture was 
stirred at 50 °C using a heating mantle for 30 min. The reac-
tion mixture was then filtered over a pad of Celite and concen-
trated under reduced pressure. After evaporation of the solvent 
under reduced pressure, the crude residue was purified by 
flash column chromatography over silica gel. 
(E)-2-(Allyloxy)-N-(tert-butyl)-4-(4-methoxyphenyl)but-
3-enamide (6a). Yellow oil, 492 mg, 81% isolated yield. 
Rf = 0.33 (PE/Et2O = 6:4). 1H NMR (400 MHz, CDCl3) δ 7.33 
(d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 6.64 (dd, 
J = 15.9, 0.7 Hz, 1H), 6.50 (brs, 1H), 6.02 (dd, J = 15.9, 
6.6 Hz, 1H), 5.99-5.87 (m, 1H), 5.42-5.06 (m, 2H), 4.29 (dd, 
J = 6.6, 1.3 Hz, 1H), 4.23-3.94 (m, 2H), 3.80 (s, 3H), 1.37 (s, 
9H). 13C{1H} NMR (101 MHz, CDCl3) δ 169.9, 159.6, 134.0, 
133.1, 129.1, 128.1, 122.9, 117.8, 114.0, 80.9, 70.4, 55.4, 
51.0, 28.9. IR (thin film): 3406, 2966, 2934, 2868, 1675, 1606, 
1510, 1454, 1364, 1249, 1174, 1032, 967, 734 cm-1. HRMS 
(ESI) m/z: [M]+ calcd for C18H25NO3 303.1834; Found 
303.1843. 
(E)-2-(Allyloxy)-N-cyclohexyl-4-(4-methoxyphenyl)but-
3-enamide (6b). Yellow solid, 525 mg, 80% isolated yield. 
Rf = 0.33 (PE/Et2O = 4:6). mp = 83-85 °C. 1H NMR 
(400 MHz, CDCl3) δ 7.30 (d, J = 8.7 Hz, 2H), 6.81 (d, 
J = 8.7 Hz, 2H), 6.63 (d, J = 15.6 Hz, 1H), 6.55 (br, 1H), 6.02 
 
 
(dd, J = 15.6, 6.6 Hz, 1H), 5.97-5.83 (m, 1H), 5.34-5.17 (m, 
2H), 4.37 (dd, J = 6.6, 1.3 Hz, 1H), 4.20-3.91 (m, 2H), 3.85-
3.63 (m, 1H), 3.76 (s, 3H), 1.97-1.79 (m, 2H), 1.77-1.51 (m, 
3H), 1.46-1.27 (m, 2H), 1.23-1.07 (m, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 169.7, 159.4, 133.8, 132.9, 128.9, 127.9, 
122.7, 117.8, 113.9, 80.3, 70.3, 55.2, 47.7, 33.1, 33.0, 25.5, 
24.8. IR (thin film): 3409, 3312, 2930, 2854, 1667, 1606, 
1509, 1450, 1249, 1032, 823, 733 cm-1. HRMS (ESI) m/z: 
[M]+ calcd for C20H27NO3 329.1991; Found 329.1997. 
(E)-2-(Allyloxy)-N-(tert-butyl)-4-phenylbut-3-enamide 
(6c). Yellow oil, 437 mg, 77% isolated yield. Rf = 0.35 
(PE/Et2O = 7:3). 1H NMR (400 MHz, CDCl3) δ 7.43-7.26 (m, 
5H), 6.72 (dd, J = 16.0, 1.1 Hz, 1H), 6.52 (brs, 1H), 6.21 (dd, 
J = 16.0, 6.4 Hz, 1H), 6.08-5.79 (m, 1H), 5.45-5.14 (m, 2H), 
4.34 (dd, J = 6.4, 1.4 Hz, 1H), 4.25-3.93 (m, 2H), 1.39 (s, 9H). 
13C{1H} NMR (101 MHz, CDCl3) δ 169.7, 136.3, 133.9, 
133.3, 128.6, 128.0, 126.8, 125.3, 117.9, 80.8, 70.6, 51.1, 
28.9. IR (thin film): 3407, 3026, 2967, 2868, 1677, 1514, 
1451, 1364, 1225, 1071, 1044, 966, 734 cm-1. HRMS (ESI) 
m/z: [M]+ calcd for C17H23NO2 273.1729; Found 273.1716. 
(E)-2-(Allyloxy)-N-cyclohexyl-4-(furan-2-yl)but-3-
enamide (6d). Yellow oil, 240 mg, 83% isolated yield. 
Rf = 0.33 (PE/Et2O = 1:1). 1H NMR (400 MHz, CDCl3) δ 7.34 
(d, J = 1.6 Hz, 1H), 6.53 (dd, J = 15.9, 1.3 Hz, 1H), 6.50 (brs, 
1H), 6.36 (dd, J = 3.3, 1.6 Hz, 1H), 6.27 (d, J = 3.3 Hz, 1H), 
6.13 (dd, J = 15.9, 6.3 Hz, 1H), 5.98-5.83 (m, 1H), 5.37-5.17 
(m, 2H), 4.38 (dd, J = 6.3, 1.3 Hz, 1H), 4.20-3.96 (m, 2H), 
3.84-3.69 (m, 1H), 1.97-1.79 (m, 2H), 1.75-1.53 (m, 3H), 
1.46-1.27 (m, 2H), 1.26-1.05 (m, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 169.4, 152.1, 142.4, 133.8, 123.9, 121.3, 
118.1, 111.5, 108.9, 80.0, 70.6, 47.8, 33.3, 33.1, 25.6, 24.9. 
IR (thin film): 3405, 3312, 2930, 2854, 1656, 1517, 1450, 
1264, 1151, 1013, 927, 731, 701 cm-1. HRMS (ESI) m/z: [M]+ 
calcd for C17H23NO3 289.1678; Found 289.1685. 
2-(Allyloxy)-N-cyclohexyl-2-(furan-2-yl)acetamide (6e). 
Yellow oil, 442 mg, 84% isolated yield. Rf = 0.40 
(PE/Et2O = 3:7). 1H NMR (400 MHz, CDCl3) δ 7.39 (dd, 
J = 1.9, 0.8 Hz, 1H), 6.74 (br, 1H), 6.39 (d, J = 3.2 Hz, 1H), 
6.34 (dd, J = 3.2, 1.9 Hz, 1H), 6.00-5.71 (m, 1H), 5.38-5.10 
(m, 2H), 4.83 (s, 1H), 4.14-3.91 (m, 2H), 3.90-3.68 (m, 1H), 
2.02-1.84 (m, 2H), 1.82-1.52 (m, 3H), 1.49-1.30 (m, 2H), 
1.29-1.09 (m, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 167.3, 
150.1, 143.3, 133.5, 118.5, 110.5, 110.5, 74.7, 70.3, 48.0, 
33.1, 25.6, 24.9. IR (thin film): 3318, 2932, 2855, 1730, 1658, 
1533, 1451, 1349, 1260, 1151, 1094, 892, 749 cm-1. HRMS 
(ESI) m/z: [M]+ calcd for C15H21NO3 263.1521; Found 
263.1514. 
General procedure for the sequential DBU-mediated 
isomerization/Claisen rearrangement of the O-allylated 
Passerini adducts. A mixture of the O-allylated Passerini 
adduct (1 equiv, 0.5 mmol), DBU (0.5 equiv, 0.25 mmol, 
0.04 mL), and toluene (2 mL, 0.25 M) was stirred at 120 °C 
for 30 min under microwave irradiation. After evaporation of 
the solvent under reduced pressure, the crude residue was 
purified by flash column chromatography over silica gel. 
N-(tert-Butyl)-3-(4-methoxybenzyl)-2-oxohex-5-enamide 
(7a). Yellow oil, 99 mg, 65% isolated yield. Rf = 0.35 
(PE/Et2O = 9:1). 1H NMR (400 MHz, CDCl3) δ 7.08 (d, 
J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 6.70 (brs, 1H), 5.81-
5.51 (m, 1H), 5.12-4.85 (m, 2H), 4.08-3.88 (m, 1H), 3.76 (s, 
3H), 2.89 (dd, J = 13.8, 7.4 Hz, 1H), 2.68 (dd, 
J = 13.8, 7.1 Hz, 1H), 2.50-2.08 (m, 2H), 1.33 (s, 9H). 
13C{1H} NMR (101 MHz, CDCl3) δ 202.4, 159.2, 158.2, 
135.1, 130.9, 130.2, 117.3, 113.9, 55.3, 51.3, 45.4, 35.8, 35.0, 
28.3. IR (thin film): 3394, 2968, 2933, 2836, 1714, 1681, 
1641, 1612, 1453, 1365, 1245, 1225, 1177, 1082, 1035, 991, 
916 cm-1. HRMS (ESI) m/z: [M]+ calcd for C18H25NO3 
303.1834; Found 303.1840. 
N-Cyclohexyl-3-(4-methoxybenzyl)-2-oxohex-5-enamide 
(7b). Yellow oil, 131 mg, 79% isolated yield. Rf = 0.33 
(PE/Et2O = 8:2). 1H NMR (400 MHz, CDCl3) δ 7.07 (d, 
J = 8.7 Hz, 2H), 6.79 (d, J = 8.7 Hz, 2H), 6.72 (br, 1H), 5.82-
5.56 (m, 1H), 5.08-4.83 (m, 2H), 4.06-3.89 (m, 1H), 3.76 (s, 
3H), 3.73-3.61 (m, 1H), 2.92 (dd, J = 13.9, 7.3 Hz, 1H), 2.68 
(dd, J = 13.9, 7.1 Hz, 1H), 2.44-2.364(m, 1H), 2.31-2.20 (m, 
1H), 1.93-1.78 (m, 2H), 1.74-1.56 (m, 3H), 1.42-1.07 (m, 5H). 
13C{1H} NMR (101 MHz, CDCl3) δ 201.7, 159.0, 158.2, 
135.1, 130.9, 130.2, 117.3, 114.0, 55.3, 48.5, 45.9, 35.7, 34.9, 
32.7, 25.5, 24.8 IR (thin film): 3370, 2930, 2854, 1714, 1668, 
1611, 1510, 1449, 1244, 1177, 1106, 1034, 915 cm-1. HRMS 
(ESI) m/z: [M]+ calcd for C20H27NO3 329.1991; Found 
329.1990. 
3-Benzyl-N-(tert-butyl)-2-oxohex-5-enamide (7c). Yellow 
oil, 121 mg, 88% isolated yield. Rf = 0.4 (PE/Et2O = 9:1). 
1H NMR (400 MHz, CDCl3) δ 7.29-6.93 (m, 5H), 6.63 (brs, 
1H), 5.74-5.43 (m, 1H), 5.06-4.73 (m, 2H), 4.14-3.75 (m, 1H), 
2.88 (dd, J = 13.8, 7.4 Hz, 1H), 2.65 (dd, J = 13.8, 7.1 Hz, 
1H), 2.44-1.95 (m, 2H), 1.26 (s, 9H). 13C{1H} NMR (101 
MHz, CDCl3) δ 202.2, 159.1, 139.0, 135.0, 129.2, 128.5, 
126.4, 117.3, 51.3, 45.1, 36.6, 35.0, 28.3. IR (thin film): 3394, 
3064, 2970, 2930, 1714, 1682, 1641, 1515, 1454, 1365, 1225, 
1072, 915, 741 cm-1. HRMS (ESI) m/z: [M]+ calcd for 
C17H23NO2 273.1729; Found 273.1733. 
N-Cyclohexyl-3-(furan-2-ylmethyl)-2-oxohex-5-enamide 
(7d). Yellow solid, 110 mg, 76% isolated yield. Rf = 0.31 
(PE/Et2O = 9:1). mp = 63-65 °C. 1H NMR (400 MHz, CDCl3) 
δ 7.25 (dd, J = 1.9, 0.8 Hz, 1H), 6.75 (br, 1H), 6.23 (dd, 
J = 3.2, 1.9 Hz, 1H), 5.98 (dd, J = 3.2, 0.7 Hz, 1H) 5.84-5.52 
(m, 1H), 5.17-4.79 (m, 2H), 4.07-3.94 (m, 1H), 3.79-3.64 (m, 
1H), 2.99 (dd, J = 15.2, 7.8 Hz, 1H), 2.89 (dd, J = 15.2, 6.1 
Hz, 1H), 2.47-2.36 (m, 1H), 2.34-2.24 (m, 1H), 1.96-1.82 (m, 
2H), 1.77-1.66 (m, 3H), 1.67-1.54 (m, 2H), 1.44-1.30 (m, 2H), 
1.26-1.09 (m, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 201.1, 
158.9, 152.9, 141.5, 134.6, 117.8, 110.3, 106.7, 48.5, 43.4, 
35.1, 32.8, 28.6, 25.5, 24.8. IR (thin film): 3371, 3318, 2930, 
1717, 1667, 1517, 1450, 1372, 1147, 1108, 1011, 917, 
728 cm-1. HRMS (ESI) m/z: [M]+ calcd for C17H23NO3 
289.1678; Found 289.1668. 
General procedure for the sequential DBU-mediated isom-
erization/Claisen rearrangement/amine addition on the O-
allylated Pudovik adducts. A solution of the O-allylated Pu-
dovik adduct (0.5 mmol, 1 equiv.), DBU (0.04 mL, 
0.25 mmol, 0.5 equiv.), and the amine (0.75 mmol, 1.5 equiv.) 
in toluene (1 mL, 0.5 M) was stirred at 130 °C for 30 min 
under microwave irradiation. After evaporation of the solvent 
under reduced pressure, the crude residue was purified by 
flash column chromatography over silica gel. 
2-Benzyl-N-(2-methylallyl)pent-4-enamide (9a). White 
solid, 73 mg, 60% isolated yield. Rf = 0.31 (PE/Et2O = 7:3). 
mp = 45-47 °C. 1H NMR (400 MHz, CDCl3) δ 7.33-7.07 (m, 
5H), 5.83-5.70 (m, 1H), 5.36 (brs, 1H), 5.10 (ddd, J = 17.0, 
3.2, 1.4 Hz, 1H), 5.13-5.02 (m, 2H), 4.70-4.68 (m, 1H), 4.55-
4.53 (m, 1H), 3.68 (d, J = 5.9 Hz, 2H), 2.93 (dd, 
J = 13.5, 9.3 Hz, 1H), 2.76 (dd, J = 13.5, 5.3 Hz, 1H), 2.51-
2.42 (m, 1H), 2.37 (ddd, J = 18.0, 9.0, 5.2 Hz, 1H) 2.30-2.21 
(m, 1H), 1.56 (s, 3H). 13C{1H} NMR (101 MHz, CDCl3) 
δ 174.1, 141.9, 139.8, 135.8, 129.1, 128.5, 126.4, 117.2, 
111.0, 50.4, 44.9, 38.8, 37.0, 20.3. IR (thin film): 3444, 3045, 
2919, 1675, 1604, 1516, 1454, 1202 cm-1. HRMS (ESI) m/z: 




(9b). White solid, 90 mg, 66% isolated yield. Rf = 0.37 
(PE/Et2O = 7:3). mp = 69-71 °C. 1H NMR (400 MHz, CDCl3) 
δ 7.18 (td, J = 7.9, 1.7 Hz, 1H), 7.10 (dd, J = 7.4, 1.5 Hz, 1H), 
6.87-6.82 (m, 2H), 5.89-5.79 (m, 1H), 5.42 (brs, 1H), 5.16-
5.04 (m, 2H), 4.76-4.74 (m, 1H), 4.64-4.62 (m, 1H), 3.82 (s, 
3H), 3.73 (d, J = 6.0 Hz, 2H), 2.87-2.80 (m, 2H), 2.56-2.39 
(m, 2H), 2.29-2.15 (m, 1H), 1.57 (s, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 174.6, 157.4, 142.2, 136.2, 131.2, 128.0, 
127.8, 120.6, 116.7, 110.9, 110.3, 55.4, 47.7, 44.8, 36.9, 33.7, 
20.3. IR (thin film): 3044, 3045, 2986, 2839, 1674, 1602, 
1515, 1466, 1241, 1031 cm-1. HRMS (ESI) m/z: [M]+ calcd for 
C17H23NO2 273.1729; Found 273.1727. 
2-(4-Methoxybenzyl)-N-(2-methylallyl)pent-4-enamide 
(9c). White solid, 88 mg, 64% isolated yield. Rf = 0.25 
(PE/Et2O = 6:4). mp = 63-65 °C. 1H NMR (400 MHz, CDCl3) 
δ 7.06 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 5.76 (ddt, 
J = 17.1, 10.1, 6.9 Hz, 1H), 5.55 (brs, 1H), 5.10-5.00 (m, 2H), 
4.69 (s, 1H), 4.56 (s, 1H), 3.75 (s, 3H), 3.67 (d, J = 5.9 Hz, 
1H), 2.85 (dd, J = 13.6, 9.1 Hz, 1H), 2.68 (dd, J = 13.6, 
5.3 Hz, 1H), 2.49-2.29 (m, 2H), 2.28-2.15 (m, 1H), 1.56 (s, 
3H). 13C{1H} NMR (101 MHz, CDCl3) δ 174.2, 158.1, 141.9, 
135.8, 131.8, 130.0, 117.0, 113.9, 110.9, 55.3, 50.3, 44.8, 
37.8, 36.9, 20.3. IR (thin film): 3444, 3055, 2986, 2921, 2852, 
1671, 1613, 1515, 1452, 1232, 1035 cm-1. HRMS (ESI) m/z: 
[M]+ calcd for C17H23NO2 273.1729; Found 273.1730. 
N-Butyl-2-(4-methoxybenzyl)pent-4-enamide (9d). 
Yellow oil, 106 mg, 77% isolated yield. Rf = 0.35 
(PE/Et2O = 1:1). 1H NMR (400 MHz, CDCl3) δ 7.07 (d, 
J = 8.6 Hz, 2H), 6.80 (d, J = 8.6 Hz, 2H), 5.82-5.69 (m, 1H), 
5.13 (brs, 1H), 5.11-5.00 (m, 2H), 3.77 (s, 3H), 3.22-3.01 (m, 
2H), 2.84 (dd, J = 13.6, 9.2 Hz, 1H), 2.69 (dd, J = 13.6, 
5.0 Hz, 1H), 2.50-2.36 (m, 1H), 2.30-2.13 (m, 2H), 1.34-1.22 
(m, 2H), 1.21-1.07 (m, 2H), 0.83 (t, J = 7.3 Hz, 3H). 13C{1H} 
NMR (101 MHz, CDCl3) δ 174.2, 158.2, 136.0, 132.0, 130.0, 
117.0, 113.9, 55.4, 50.5, 39.1, 38.0, 36.9, 31.7, 20.0, 13.8. IR 
(thin film): 3292, 2956, 2931, 1639, 1549, 1511, 1242, 1176, 
1036, 912 cm-1. HRMS (ESI) m/z: [M]+ calcd for C17H25NO2 
275.1885; Found 275.1877. 
2-(4-Methoxybenzyl)-1-(piperidin-1-yl)pent-4-en-1-one 
(9e). Yellow oil, 55 mg, 38% isolated yield. Rf = 0.35 
(PE/Et2O = 1:1). 1H NMR (400 MHz, CDCl3) δ 7.01 (d, 
J = 8.6 Hz, 2H), 6.72 (d, J = 8.6 Hz, 2H), 5.78-5.51 (m, 1H), 
5.06-4.79 (m, 2H), 3.70 (s, 3H), 3.56-3.28 (m, 2H), 3.19-2.98 
(m, 2H), 2.94-2.85 (m, 1H), 2.80 (dd, J = 13.0, 9.3 Hz, 1H), 
2.61 (dd, J = 13.0, 5.1 Hz, 1H), 2.44-2.35 (m, 1H), 2.23-2.07 
(m, 1H), 1.48-1.18 (m, 5H), 0.96-0.83 (m, 1H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 172.9, 158.1, 136.1, 132.1, 130.1, 116.6, 
113.7, 55.3, 46.7, 43.2, 42.9, 38.2, 37.2, 26.3, 25.8, 24.6. 
IR (thin film): 2936, 2856, 1624, 1511, 1442, 1243, 1035, 
732 cm-1. HRMS (ESI) m/z: [M]+ calcd for C18H25NO2 
287.1885; Found 287.1818. 
General procedure for the sequential DBU-mediated isom-
erization/Claisen rearrangement/indole addition on the O-
allylated Pudovik adducts. A solution of the O-allylated Pu-
dovik adduct (0.5 mmol), DBU (0.04 mL, 0.25 mmol, 
0.5 equiv.) and the indole (0.5 mmol, 1 equiv.) in 
toluene (1 mL, 0.5 M) was stirred at 140 °C for 30 min under 
microwave irradiation. After evaporation of the solvent under 
reduced pressure, the crude residue was purified by flash 
column chromatography over silica gel. 
1-(1H-Indol-1-yl)-2-(4-methoxybenzyl)pent-4-en-1-one 
(9f). Colorless oil, 101 mg, 63% isolated yield. Rf = 0.34 
(PE/Et2O = 9:1). 1H NMR (CDCl3, 400 MHz) δ 8.53 (d, 
J = 8.3 Hz, 1H), 7.53 (dd, J = 7.8, 0.6 Hz, 1H), 7.38-7.33 (m, 
1H), 7.31 (d, J = 3.8 Hz, 1H), 7.29-7.24 (m, 1H), 7.10 (d, 
J = 8.6Hz, 2H), 6.76 (d, J = 8.6Hz, 2H), 6.55 (dd, J = 3.8, 
0.6 Hz, 1H), 5.84-5.75 (m, 1H), 5.13-5.01 (m, 2H), 3.74 (s, 
3H), 3.45-3.40 (m, 1H), 3.14 (dd, J = 13.8, 8.1 Hz, 1H), 2.89 
(dd, J = 13.8, 6.1 Hz, 1H), 2.68-2.61 (m, 1H), 2.46-2.40 (m, 
1H). 13C{1H} NMR (101 MHz, CDCl3) δ 173.9, 158.4, 135.8, 
134.8, 130.9, 130.6, 130.0, 125.2, 124.6, 123.8, 120.8, 117.9, 
117.1, 114.1, 109.2, 55.34, 47.3, 37.6, 36.8. IR (thin film): 
3074, 2997, 2835, 1697, 1583, 1300, 1203, 1033, 920, 
818 cm-1. HRMS (ESI) m/z: [M]+ calcd for C21H21NO2 
319.1572; Found 319.1584. 
Methyl 1-[2-(4-methoxybenzyl)pent-4-enoyl]-1H-indole-
3-carboxylate (9g). White solid, 77 mg, 41% isolated yield. 
Rf = 0.29 (PE/Et2O = 8:2). mp = 85 °C. 1H NMR (CDCl3, 
400 MHz) δ 8.50 (d, J = 7.4 Hz, 1H), 8.12 (d, J = 6.8 Hz, 1H), 
7.95 (s, 1H), 7.46-7.32 (m, 2H), 7.07 (d, J = 8.6 Hz, 2H), 6.74 
(d, J = 8.6 Hz, 2H), 5.83-5.78 (m, 1H), 5.21-4.90 (m, 2H), 
3.93 (s, 3H), 3.72 (s, 3H), 3.48-3.41 (m, 1H), 3.10 (dd, 
J = 13.8, 8.5 Hz, 1H), 2.94 (dd, J = 13.8, 5.8 Hz, 1H), 2.68-
2.61 (m, 1H), 2.52-2.38 (m, 1H). 13C{1H} NMR (101 MHz, 
CDCl3) δ 174.2, 164.5, 158.5, 136.1, 134.2, 130.6, 130.4, 
129.9, 127.5, 126.0, 125.0, 121.5, 118.4, 116.9, 114.2, 113.7, 
55.3, 51.7, 47.5, 37.7, 36.8. IR (thin film): 2949, 2835, 1704, 
1640, 1550, 1245, 1185, 1102 cm-1. HRMS (ESI) m/z: [M]+ 
calcd for C23H23NO4 377.1627; Found 377.1630. 
1-(1H-Indol-1-yl)-2-(2-methoxybenzyl)pent-4-en-1-one 
(9h). Brown oil, 98 mg, 61% isolated yield. Rf = 0.4 
(PE/Et2O = 9.5:0.5). 1H NMR (400 MHz, CDCl3) δ 8.57 (d, 
J = 8.3 Hz, 1H), 7.61-7.45 (m, 2H), 7.41-7.33 (m, 1H), 7.27 
(td, J = 7.5, 1.1 Hz, 1H), 7.20 (td, J = 7.9, 1.7 Hz, 1H), 7.14 
(dd, J = 7.5, 1.4 Hz, 1H), 6.86-6.82 (m, 2H), 6.56 (dd, J = 3.8, 
0.6 Hz, 1H), 5.83-5.78 (m; 1H), 5.10-4.97 (m, 2H), 3.81 (s, 
3H), 3.65-3.60 (m, 1H) 3.21 (dd, J = 13.3, 6.6 Hz, 1H), 2.90 
(dd, J = 13.3, 7.5 Hz, 1H), 2.73-2.68 (m, 1H), 2.38-2.31 (m, 
1H). 13C{1H} NMR (101 MHz, CDCl3) δ 174.3, 157.5, 135.8, 
135.4, 131.5, 130.6, 128.3, 126.9, 125.0, 124.9, 123.7, 120.7, 
120.6, 117.2, 117.1, 110.4, 108.7, 55.3, 44.4, 36.0, 34.6. 
IR (thin film): 3074, 2997, 2836, 1700, 1493, 1314, 1205, 
1050, 919, 897 cm-1. HRMS (ESI) m/z: [M]+ calcd for 
C21H21NO2 319.1572; Found 319.1573. 
General procedure for the sequential DBU-mediated 
isomerization/Claisen rearrangement/nucleophilic addi-
tion. A mixture of the O-allylated Pudovik adduct (0.5 mmol), 
DBU (0.04 mL, 0.25 mmol, 0.5 equiv.) and the corresponding 
alcohol (1 mL, 0.5 M) or a 2:1 toluene/thiol mixture was 
stirred at 140 °C for 30 min under microwave irradiation. 
After evaporation of the solvent under reduced pressure, the 
crude residue was purified by flash column chromatography 
over silica gel. 
Ethyl 2-(2-methoxybenzyl)pent-4-enoate (9i). Colourless 
oil, 111 mg, 89% isolated yield. Rf = 0.3 (PE/Et2O = 9.5:0.5). 
1H NMR (400 MHz, CDCl3) δ 7.19 (td, J = 7.9, 1.7 Hz, 1H), 
7.10 (dd, J = 7.3, 1.5 Hz, 1H), 6.87-6.82 (m, 2H), 5.80-5.72 
(m, 1H), 5.09-5.00 (m, 2H), 4.04 (qd, J = 7.1, 2.0 Hz, 2H), 
3.82 (s, 3H), 2.87-2.81 (m, 3H), 2.38 (m, 1H), 2.27 (m, 1H), 
1.13 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3) 
δ 175.4, 157.7, 135.7, 130.9, 127.8, 127.7, 120.3, 116.8, 
110.3, 60.2, 55.3, 45.3, 36.5, 33.0, 14.3. IR (thin film): 2978, 
2936, 2361, 1729, 1601, 1289, 1176, 1050, 917, 855 cm-1. 
HRMS (ESI) m/z: [M]+ calcd for C15H20O3 248.1412; Found 
248.1414. 
2,2,2-Trifluoroethyl-2-(4-methoxybenzyl)pent-4-enoate 
(9j). Colourless oil, 80 mg, 53% isolated yield. Rf = 0.35 
(PE/Et2O = 9:1). 1H NMR (400 MHz, CDCl3) δ 7.08 (d, 
J = 8.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 5.80-5.70 (m, 1H), 
 
 
5.11-5.06 (m, 2H), 4.49-4.29 (m, 2H), 3.79 (s, 3H), 2.94-2.76 
(m, 3H), 2.44-2.29 (m, 2H). 13C{1H} NMR (101 MHz, 
CDCl3) δ 173.4, 158.4, 134.6, 130.6, 129.9, 123.1(q, J = 277.1 
Hz), 114.0, 60.2 (q, J = 36.6 Hz), 55.3, 47.4, 36.8, 35.9. 
IR (thin film): 2949, 2835, 1704, 1640, 1550, 1245, 1185, 
1102 cm-1. HRMS (ESI) m/z: [M]+ calcd for C15H17F3O3 
302.1130; Found 302.1142. 
S-Ethyl 2-(4-methoxybenzyl)pent-4-enethioate (9k). 
Yellow oil, 88 mg, 67% isolated yield. Rf = 0.35 
(PE/Et2O = 9.5:0.5). 1H NMR (400 MHz, CDCl3) δ 7.06 (d, 
J = 8.6 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 5.74 (ddt, J = 17.1, 
10.2, 7.0 Hz, 1H), 5.28-4.71 (m, 2H), 3.78 (s, 3H), 2.99-2.77 
(m, 4H), 2.70 (dd, J = 13.0, 6.1 Hz, 1H), 2.48-2.34 (m, 1H), 
2.31-2.15 (m, 1H), 1.18 (t, J = 7.4 Hz, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 202.4, 158.3, 135.0, 131.0, 130.2, 117.4, 
113.9, 56.0, 55.3, 37.5, 36.5, 23.3, 14.9. IR (thin film): 3045, 
2933, 2840, 1680, 1613, 1513, 1448, 1299, 1230, 1179, 1035, 
925 cm-1. HRMS (ESI) m/z: [M]+ calcd for C15H20O2S 
264.1184; Found 264.1186. 
General procedure for the sequential [Ru-H]-catalyzed 
isomerization/Claisen rearrangement. A solution of the 
O-allylated Pudovik or Passerini adduct (0.5 mmol), 
RuClH(CO)(PPh3)3 (0.025 mmol, 0.05 equiv.) in toluene 
(1 mL, 0.5M) was heated under microwave irradiation at the 
indicated temperature for 30 min. After evaporation, the crude 
residue was purified by flash column chromatography over 
silica gel. 
(E)-Diethyl (3-(4-methoxyphenyl)-4-methyl-5-oxopent-1-
en-1-yl)phosphonate (10a). It was unfortunately impossible 
to separate and precisely distinguish the syn from the anti 
isomer (dr = 1:1). Yellow oil, 112 mg, 66% 41% isolated 
yield. Rf = 0.43 (CH2Cl2/AcOEt = 6:4). First diasteroisomer: 
1H NMR (400 MHz, CDCl3) δ 9.68 (d, J = 2.4 Hz, 1H), 7.09 
(d, J = 8.7 Hz, 2H), 6.95-6.79 (m, 3H), 5.81-5.44 (m, 1H), 
4.10-3.91 (m, 8H), 3.78 (s, 3H), 3.70-3.59 (m, 1H), 2.95-2.62 
(m, 1H), 1.37-1.19 (m, 6H), 0.93 (d, J = 7.1 Hz, 3H). 
13C{1H} NMR (101 MHz, CDCl3) δ 203.3, 158.9, 153.1 (d, 
J = 5.0 Hz), 131.1, 129.5, 119.6 (d, J = 62.8 Hz), 114.5, 70.0 
(d, J = 5.0 Hz), 55.4, 51.0 (d, J = 21.7 Hz), 50.3, 16.5 (d, 
J = 3.8 Hz), 12.6. Second diasteroisomer: 1H NMR 
(400 MHz, CDCl3) δ 9.49 (d, J = 2.3 Hz, 1H), 7.05 (d, 
J = 8.7 Hz, 2H), 6.95-6.79 (m, 3H), 5.81-5.44 (m, 1H), 4.10-
3.91 (m, 8H), 3.77 (s, 3H), 3.70-3.59 (m, 1H), 2.95-2.62 (m, 
1H), 1.37-1.19 (m, 6H), 1.14 (d, J = 7.0 Hz, 3H). 13C{1H} 
NMR (101 MHz, CDCl3) δ 203.2, 158.9, 152.4 (d, J = 5.1 
Hz), 130.5, 129.2, 117.7 (d, J = 62.9 Hz), 114.4, 61.9 (d, 
J = 5.6 Hz), 55.4, 50.2, 50.1 (d, J = 21.7 Hz), 16.4 (d, 
J = 3.2 Hz), 12.4. IR (thin film): 2980, 2934, 2906, 2837, 
1722, 1608, 1511, 1246, 1177, 1018, 962, 833, 722 cm-1. 
HRMS (ESI) m/z: [M]+ calcd for C17H25O5P 340.1440; Found 
340.1439. 
(E)-N-(tert-butyl)-4-(4-methoxyphenyl)-5-methyl-6-
oxohex-2-enamide (10b). It was unfortunately impossible to 
separate and precisely distinguish the syn from the anti isomer 
(dr = 1:1). Yellow oil, 105 mg, 69% isolated yield. Rf = 0.3 
(PE/Et2O = 3:7). First diasteroisomer: 1H NMR (400 MHz, 
CDCl3) δ 9.70 (d, J = 2.3 Hz, 1H), 7.10 (d, J = 8.7 Hz, 2H), 
6.98-6.88 (m, 1H), 6.85 (d, J = 8.7 Hz, 2H), 5.81-5.54 (m, 
1H), 5.32 (brs, 1H), 3.78 (s, 3H), 3.65-3.56 (m, 1H), 2.89-2.67 
(m, 1H), 1.34 (s, 9H), 1.14 (d, J = 7.0 Hz, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 204.1, 164.6, 158.8, 143.6, 143.0, 132.1, 
131.5, 129.4, 129.2, 126.3, 125.8, 114.4, 114.3, 55.4, 51.5, 
50.7, 48.9, 28.9, 12.5.	 Second diasteroisomer: 1H NMR 
(400 MHz, CDCl3) δ 9.50 (d, J = 2.3 Hz, 1H), 7.07 (d, 
J = 8.7 Hz, 1H), 6.98-6.88 (m, 1H), 6.84 (d, J = 8.7 Hz, 2H), 
5.81-5.54 (m, 1H), 5.32 (brs, 1H), 3.77 (s, 3H), 3.65-3.56 (m, 
1H), 2.89-2.67 (m, 1H), 1.33 (s, 9H), 0.91 (d, J = 7.1 Hz, 3H). 
13C{1H} NMR (101 MHz, CDCl3) δ 203.9, 164.6, 158.7, 
143.6, 143.0, 132.1, 131.5, 129.4, 129.2, 126.3, 125.8, 114.4, 
114.3, 55.4, 51.5, 50.6, 48.4, 28.9, 12.4.	IR (thin film): 3316, 
2968, 2934, 2838, 1722, 1670, 1634, 1610, 1511, 1422, 1392, 
1364, 1264, 1250, 1179, 1034, 981, 731 cm-1. HRMS (ESI) 
m/z: [M]+ calcd for C18H25NO3 303.1834; Found 303.1843. 
(E)-N-Cyclohexyl-4-(4-methoxyphenyl)-5-methyl-6-
oxohex-2-enamide (10c). It was unfortunately impossible to 
separate and precisely distinguish the syn from the anti isomer 
(dr = 1:1). Brown solid, 140 mg, 85% isolated yield. Rf = 0.3 
(PE/Et2O = 2:8). mp = 146 °C. First diasteroisomer: 
1H NMR (400 MHz, CDCl3) δ 9.69 (d, J = 2.4 Hz, 1H), 7.10 
(d, J = 8.7 Hz, 2H), 7.00-6.90 (m, 1H), 6.85 (d, J = 8.7 Hz, 
2H), 5.71 (dd, J = 15.1, 1.1 Hz, 1H), 5.45 (br, 1H), 3.83-3.72 
(m, 1H), 3.78 (s, 3H), 3.66-3.56 (m, 1H), 2.86-2.77 (m, 1H), 
1.94-1.81 (m, 2H), 1.73-1.54 (m, 3H), 1.40-1.27 (m, 2H), 1.13 
(d, J = 7.0 Hz, 3H), 1.18-1.00 (m, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 204.0, 164.3, 158.7, 144.0, 143.4, 132.0, 
131.4, 129.4, 129.2, 125.5, 125.0, 114.4, 114.3, 55.4, 50.6, 
49.0, 48.4, 33.2, 25.6, 24.9, 12.5, 12.4. Second diasteroiso-
mer: 1H NMR (400 MHz, CDCl3) δ 9.50 (d, J = 2.4 Hz, 1H), 
7.07 (d, J = 8.7 Hz, 2H), 7.00-6.90 (m, 1H), 6.83 (d, J = 8.7 
Hz, 2H), 5.71 (dd, J = 15.1, 1.1 Hz, 1H), 5.45 (br, 1H), 3.83-
3.72 (m, 1H), 3.76 (s, 3H), 3.66-3.56 (m, 1H), 2.86-2.77 (m, 
1H), 1.94-1.81 (m, 2H), 1.73-1.54 (m, 3H), 1.40-1.27 (m, 2H), 
1.18-1.00 (m, 3H), 0.91 (d, J = 7.1 Hz, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 203.9, 164.3, 158.7, 144.0, 143.4, 132.0, 
131.4, 129.4, 129.2, 125.5, 125.0, 114.4, 114.3, 55.4, 50.6, 
49.0, 48.3, 33.2, 25.6, 24.9, 12.5, 12.4. IR (thin film): 3287, 
2952, 2854, 1722, 1665, 1625, 1511, 1264, 1249, 1179, 1033, 
981, 732 cm-1. HRMS (ESI) m/z: [M]+ calcd for C20H27NO3 
329.1991; Found 329.2000. 
(E)-N-(tert-Butyl)-5-methyl-6-oxo-4-phenylhex-2-
enamide (10d). It was unfortunately impossible to separate 
and precisely distinguish the syn from the anti isomer 
(dr = 1:1). Yellow oil, 107 mg, 78% isolated yield. Rf = 0.28 
(PE/Et2O = 4:6). First diasteroisomer: 1H NMR (400 MHz, 
CDCl3) δ 9.70 (d, J = 2.4 Hz, 1H), 7.43-7.07 (m, 5H), 6.98-
6.91 (m, 1H), 5.71 (d, J = 15.1 Hz, 1H), 5.47 (br, 1H), 3.69-
3.60 (m, 1H), 2.92-2.76 (m, 1H), 1.33 (s, 9H), 1.13 (d, 
J = 7.0 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 203.9, 
164.6, 143.2, 140.2, 139.5, 129.0, 129.0, 128.4, 128.1, 127.3, 
126.6, 126.1, 51.4, 50.6, 49.6, 28.8, 12.5. Second diastero-
isomer: 1H NMR (400 MHz, CDCl3) δ 9.50 (d, J = 2.2 Hz, 
1H), 7.43-7.07 (m, 5H), 6.98-6.91 (m, 1H), 5.71 (d, J = 15.1 
Hz, 1H), 5.47 (br, 1H), 3.69-3.60 (m, 1H), 2.92-2.76 (m, 1H), 
1.32 (s, 9H), 0.90 (d, J = 7.1 Hz, 3H). 13C{1H} NMR 
(101 MHz, CDCl3) δ 203.7, 164.5, 142.5, 140.2, 139.5, 129.0, 
129.0, 128.4, 128.1, 127.3, 126.6, 126.1, 51.4, 50.4, 49.2, 
28.8, 12.4. IR (thin film): 3295, 3062, 2968, 2932, 1721, 1666, 
1628, 1538, 1453, 1362, 1265, 1222, 981, 910, 734 cm-1. 
HRMS (ESI) m/z: [M]+ calcd for C17H23NO2 273.1729; Found 
273.1737. 
General procedure for the sequential [Ru-H]-catalyzed 
isomerization/Claisen rearrangement of the heteroaromatic O-
allylated Passerini and Pudovik adducts. To a  
solution of the O-allylated Pudovik or Passerini adduct 
(0.1 mmol) in CHCl3 (0.1M) was added RuClH(CO)(PPh3)3 
(0.005 mmol, 0.05 equiv.) and the resulting mixture was 
heated at 180 °C for 10 min under microwave irradiation. The 
reaction mixture was filtered through Celite, concentrated 
under reduced pressure and the crude residue was purified by 




phosphonate (11a). Yellow oil, 17 mg, 62% isolated yield. 
Rf = 0.32 (PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) 
δ 9.63 (d, J = 1.2 Hz, 1H), 7.33 (d, J = 1.8 Hz, 1H), 6.39 (d, 
J = 1.8 Hz, 1H), 4.09-3.99 (m, 4H), 3.81-3.73 (m, 1H), 2.89 
(d, J = 20.8 Hz, 2H), 1.41 (d, J = 7.2 Hz, 3H), 1.28-1.23 (m, 
6H). 13C{1H} NMR (101 MHz, CDCl3) δ 200.8 (d, 
J = 3.6 Hz), 142.7 (d, J = 12.2 Hz), 142.3 (d, J = 3.8 Hz), 
118.8 (d, J = 8.8 Hz), 110.2 (d, J = 3.6 Hz), 62.4 (dd, J = 6.6, 
5.0 Hz), 43.2 (d, J = 1.9 Hz), 25.4 (d, J = 144.0 Hz), 16.3 (d, 
J = 5.9 Hz), 14.1 (d, J = 2.0 Hz). IR (thin film): 2960, 1743, 
1420, 1247 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C12H19O5PNa 297.0867; Found 297.0855. 
Diethyl[(3-(1-oxopropan-2-yl)thiophen-2-
yl)methyl]phosphonate (11b). Yellow oil, 14 mg, 48% 
isolated yield. Rf = 0.33 (PE/EtOAc = 1:3). 1H NMR 
(400 MHz, CDCl3) δ 9.65 (d, J = 1.2 Hz, 1H), 7.22 (dd, 
J = 5.3, 2.5 Hz, 1H), 6.81 (d, J = 5.3 Hz, 1H), 4.11-4.03 (m, 
4H), 3.90 (q, J = 7.1 Hz, 1H), 3.37 (d, J = 2.1 Hz, 1H), 3.32 
(d, J = 2.1 Hz, 1H), 1.40 (d, J = 7.0 Hz, 3H), 1.28 (d, 
J = 7.3 Hz, 6H). 13C{1H} NMR (101 MHz, CDCl3) δ 200.7 (d, 
J = 2.9 Hz), 136.1 (d, J = 8.8 Hz), 129.1 (d, J = 10.7 Hz), 
126.9 (d, J = 3.8 Hz), 124.7 (d, J = 4.2 Hz), 62.7 (d, 
J = 6.9 Hz), 62.6 (d, J = 6.9 Hz), 46.4, 26.6 62.7 (d, J = 144.7 
Hz), 16.5 (d, J = 5.9 Hz), 14.7. IR (thin film): 2985, 2935, 
1728, 1030 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C12H19O4PSNa 313.0639; Found 313.0685. 
Diethyl[(2-(1-oxopropan-2-yl)furan-3-yl)methyl]-
phosphonate (11c). Yellow oil, 8 mg, 29% isolated yield. 
Rf = 0.30 (PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) 
δ 9.63 (d, J = 1.2 Hz, 1H), 7.33 (d, J = 1.8 Hz, 1H), 6.39 (s, 
1H), 4.07-4.01 (m, 4H), 3.77 (q, J = 7.2 Hz, 1H), 2.89 (d, 
J = 20.8 Hz, 2H), 1.41 (d, J = 7.2 Hz, 3H), 1.26 (td, J = 7.1, 
3.2 Hz, 6H). 13C{1H} NMR (101 MHz, CDCl3) δ 198.8 (d, 
J = 3.4 Hz), 148.2 (d, J = 11.2 Hz), 142.3 (d, J = 1.4 Hz), 
112.9 (d, J = 3.0 Hz), 112.3 (d, J = 9.7 Hz), 62.8 (t, 
J = 7.1 Hz), 45.0 (d, J = 1.9 Hz), 23.3 (d, J = 144.2 Hz), 16.5 
(d, J = 5.9 Hz), 12.3 (d, J = 1.9 Hz). IR (thin film): 2960, 
2935, 1420, 1247 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C12H19O5PNa 297.0867; Found 297.0855. 
Diethyl[(2-(1-oxopropan-2-yl)thiophen-3-yl)methyl]pho-
sphonate (11d). Yellow oil, 16 mg, 54% isolated yield. 
Rf = 0.32 (PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) 
δ 9.62 (d, J = 1.6 Hz, 1H), 7.24 (s, 1H), 7.04 (dd, J = 5.2, 
1.4 Hz, 1H), 4.08-3.99 (m, 4H), 3.72 (q, J = 7.0 Hz, 1H), 3.17 
(d, J = 5.9 Hz, 1H), 3.12 (d, J = 5.9 Hz, 1H), 1.49 (d, 
J = 7.1 Hz, 3H), 1.27-1.24 (m, 7H). 13C{1H} NMR (101 MHz, 
CDCl3) δ 199.3, 132.1 (d, J = 9.9 Hz), 130.2, 128.5 (d, 
J = 12.1 Hz), 124.3, 62.4, 46.2, 27.6 (d, J = 141.6 Hz), 16.4 (d, 
J = 5.9 Hz), 15.8. IR (thin film): 2980 2925, 1748, 1060 cm-1. 
HRMS (ESI) m/z: [M + Na]+ calcd for C12H19O4PSNa 
313.0639; Found 313.0685. 
Diethyl[(3-(1-oxopropan-2-yl)benzo[b]thiophen-2-yl)me-
thyl]phosphonate (11e). Yellow oil, 9.5 mg, 56% isolated 
yield. Rf = 0.42 (PE/EtOAc = 1:3). 1H NMR (400 MHz, 
CDCl3) δ 9.82 (s, 1H), 7.82-7.77 (m, 1H), 7.54-7.47 (m, 1H), 
7.34-7.29 (m, 2H), 4.16-4.04 (m, 6H), 3.45 (dq, J = 21.5, 
15.7 Hz, 2H), 1.54 (d, J = 7.1 Hz, 3H), 1.34-1.25 (m, 6H). 
13C{1H} NMR (101 MHz, CDCl3) δ 201.7 (d, J = 3.0 Hz), 
139.2, 138.4 (d, J = 3.5 Hz), 131.3 (d, J = 11.3 Hz), 130.3 (d, 
J = 9.7 Hz), 124.6, 124.5, 122.6, 122.2, 62.9 (d, J = 6.8 Hz), 
62.7 (d, J = 6.8 Hz), 46.7 (d, J = 2.0 Hz), 27.7 (d, 
J = 143.5 Hz), 16.6 (d, J = 4.5 Hz), 13.0 (d, J = 2.2 Hz). 
IR (thin film): 2995, 2910, 1748, 1045 cm-1. HRMS (ESI) m/z: 
[M + Na]+ calcd for C16H21O4PSNa 363.0795; Found 
363.0802. 
Diethyl[(2-(1-oxopropan-2-yl)benzo[b]thiophen-3-yl)me-
thyl]phosphonate (11f). Yellow oil, 7 mg, 29% isolated yield. 
Rf = 0.43 (PE/EtOAc = 1:3). 1H NMR (400 MHz, CDCl3) 
δ 9.81 (s, 1H), 7.81-7.77 (m, 1H), 7.53-7.48 (m, 1H), 7.32 
(ddd, J = 5.8, 4.3, 1.9 Hz, 2H), 4.15-4.05 (m, 5H), 3.51-3.38 
(m, 2H), 1.54 (d, J = 7.1 Hz, 3H), 1.34-1.26 (m, 6H). 
13C{1H} NMR (101 MHz, CDCl3) δ 201.7 (d, J = 3.0 Hz), 
139.2 (d, J = 1.9 Hz), 138.4 (d, J = 3.6 Hz), 131.3 (d, 
J = 11.3 Hz), 130.3 (d, J = 9.6 Hz), 124.6 (d, J = 0.7 Hz), 
124.5 (d, J = 1.4 Hz), 122.6 (d, J = 1.1 Hz), 122.3 (d, 
J = 1.3 Hz), 62.9 (d, J = 6.8 Hz), 62.7 (d, J = 6.8 Hz), 46.7 (d, 
J = 2.0 Hz), 27.6 (d, J = 143.5 Hz), 16.6 (d, J = 1.4 Hz), 16.5 
(d, J = 1.4 Hz), 13.0 (d, J = 2.2 Hz). IR (thin film): 2990, 
2925, 1728, 1030 cm-1. HRMS (ESI) m/z: [M + Na]+ calcd for 
C16H21O4PSNa 363.0795; Found 363.0802. 
N-Cyclohexyl-2-[3-(1-oxopropan-2-yl)furan-2-
yl]acetamide (11g). Yellow oil, 83 mg, 63% isolated yield. 
Rf = 0.33 (PE/Et2O = 2:8).	1H NMR (400 MHz, CDCl3) δ 9.60 
(d, J = 1.1 Hz, 1H), 7.34 (d, J = 1.8 Hz, 1H), 6.22 (d, 
J = 1.8 Hz, 1H), 5.78 (br, 1H), 3.74-3.62 (m, 1H), 3.57-3.43 
(m, 3H), 1.86-1.75 (m, 2H), 1.67-1.50 (m, 3H), 1.41-1.22 (m, 
5H), 1.17-1.00 (m, 3H). 13C{1H} NMR (101 MHz, CDCl3) 
δ 201.0, 167.2, 146.2, 142.5, 118.8, 110.3, 48.5, 43.3, 34.9, 
32.9, 32.9, 25.5, 24.8, 14.1	 IR (thin film): 3296, 2929, 2854, 
1644, 1538, 1450, 1350, 1249, 892, 736 cm-1. HRMS (ESI) 
m/z: [M]+ calcd for C15H21NO3 263.1521; Found 263.1526. 
Diethyl [(4-(1-oxopropan-2-yl)quinolin-3-yl)methyl)-
phosphonate (11h). Yellow oil, 75 mg, 45% isolated yield. 
Rf = 0.10 (AcOEt = 100%). 1H NMR (400 MHz, CDCl3) 
δ 9.89 (s, 1H), 8.81 (d, J = 1.6 Hz, 1H), 8.12 (d, J = 8.3 Hz, 
1H), 7.74-7.60 (m, 2H), 7.58-7.43 (m, 1H), 4.33 (q, 
J = 7.0 Hz, 1H), 4.18-3.92 (m, 4H), 3.41 (dd, J = 21.7, 
12.2 Hz, 2H), 1.66 (d, J = 7.0 Hz, 3H), 1.31 (t, J = 7.1 Hz, 
3H), 1.21 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (101 MHz, 
CDCl3) δ 202.2 (d, J = 2.2 Hz), 152.9 (d, J = 4.4 Hz), 148.1 
(d, J = 2.8 Hz), 143.3 (d, J = 7.6 Hz), 130.8 (d, J = 1.3 Hz), 
129.2 (d, J = 1.2 Hz), 127.5 (d, J = 0.9 Hz), 126.6 (d, 
J = 3.2 Hz), 124.7 (d, J = 9.7 Hz), 124.2 (d, J = 1.0 Hz), 62.9 
(d, J = 7.0 Hz), 62.6 (d, J = 6.8 Hz), 48.8 (d, J = 1.6 Hz), 29.9 
(d, J = 139.1 Hz), 16.5 (d, J = 5.6 Hz), 16.5 (d, J = 5.6 Hz), 
14.0 (d, J = 1.1 Hz). IR (thin film): 2981, 2931, 2908, 1723, 
1703, 1572, 1504, 1242, 1162, 1048, 1016, 958, 795, 
763 cm-1. HRMS (ESI) m/z: [M]+ calcd for C17H22NO4P 
335.1286; Found 335.1296. 
General procedure for the ring-closing metathesis. To a 
solution of diene (0.2 mmol) in CH2Cl2 (4 mL) was added 
second generation Grubbs catalyst (0.01 mmol) and the 
resulting mixture was stirred at the indicated temperature 
using a heating mantle for the indicated amount of time. The 
reaction mixture was then filtered over a pad of Celite, 
concentrated under reduced pressure and the crude residue 
was purified by flash column chromatography.  
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